VRHI (Veri Medtech Holdings) ROC %: -20.00% (As of Dec. 2021)


VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $1.95
View Full Analysis

What is Veri Medtech Holdings ROC %?

Veri Medtech Holdings VRHI 35 ROC % is -20.00% as of Dec. 2021. GuruFocus rates VRHI with a GF Score™ of 35/100.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Veri Medtech Holdings's annualized return on capital (ROC %) for the quarter that ended in Dec. 2021 was -20.00%.

As of today (2026-06-26), Veri Medtech Holdings's WACC % is 0.00%. Veri Medtech Holdings's ROC % is 0.00% (calculated using TTM income statement data). Veri Medtech Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Veri Medtech Holdings  (OTCPK:VRHI) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Veri Medtech Holdings's WACC % is 0.00%. Veri Medtech Holdings's ROC % is 0.00% (calculated using TTM income statement data). Veri Medtech Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Veri Medtech Holdings ROC % Related Terms


Veri Medtech Holdings ROC % Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings ROC % Chart

Veri Medtech Holdings Annual Data
Trend Dec21
ROC %
-20.00

Veri Medtech Holdings Semi-Annual Data
Dec21
ROC % -20.00
VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings ROC % Calculation

Veri Medtech Holdings's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2021 is calculated as:

ROC % (A: Dec. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: . 20 ) + Invested Capital (A: Dec. 2021 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Veri Medtech Holdings's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2021 is calculated as:

ROC % (Q: Dec. 2021 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: Dec. 2021 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (Dec. 2021) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -20.00% mean?
Veri Medtech Holdings (VRHI) has a ROC % of -20.00% as of Dec. 2021. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' ROC % too high?
Veri Medtech Holdings' current ROC % is -20.00%. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' ROC % compare to MMVVF and BLMZ?
Veri Medtech Holdings' ROC % of -20.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.06, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Veri Medtech Holdings and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veri Medtech Holdings's current ROC % is -20.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHI) has a current ROC % of -20.00%. The current ROC % is -20.00%. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Veri Medtech Holdings (VRHI), the current ROC % is -20.00% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price